Match tier Listed
Presence Current · Arkansas
Last published 2020
Sources OpenAlex · ORCID
Refreshed 2026-10-08

David L. Avery

Senior Director of Clinical Research Operations

7 h-index 9 pubs 292 cited

  • Female
  • Animals
  • Mice
  • Male
  • Pregnancy
  • Dose-Response Relationship, Drug
  • Humans
  • Diazinon
  • Insecticides
  • Mice, Inbred Strains
  • Body Weight
  • Pandemics
  • Hemolytic Plaque Technique
  • Prenatal Exposure Delayed Effects
  • Bortezomib

Biography and Research Information

OverviewAI-generated summary

David L. Avery's research interests include studies on the effects of various substances and interventions on health outcomes. His work has investigated topics such as the impact of specific dietary components, the efficacy of certain treatments, and the relationship between lifestyle factors and disease. Avery has also contributed to the understanding of health disparities and the development of health sciences education.

Metrics

  • h-index: 7
  • Publications: 9
  • Citations: 292

Positions

Selected Publications

  • Provision of COVID ‐19 Convalescent Plasma in a Resource‐Constrained State (2020)
    Transfusion 6 citations DOI OpenAlex
  • Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma (2016)
    Blood Cancer Journal 34 citations DOI OpenAlex
  • Immunoteratology of chlordane: Cell-mediated and humoral immune responses in adult mice exposed in utero (1982)
    Toxicology and Applied Pharmacology 56 citations DOI OpenAlex
  • Neurobehavioral effects of prenatal exposure to the organophosphate Diazinon in mice (1977)
    Journal of Toxicology and Environmental Health 82 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

40 Collaborators 8 Institutions 1 Country

Top Collaborators

View profile →

Similar Researchers

Based on overlapping research topics